The Goldman Sachs Group vs Merck & Co. Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
The Goldman Sachs Group (GS) carries a "Neutral" signal with -3.8% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | The Goldman Sachs Group (GS) | Merck & Co. Inc. (MRK) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $20.6B | $16.3B |
| Revenue Growth | -3.8% | -2.2%* |
| Latest EPS | $17.55* | $-1.72 |
| EPS Growth | 108.9%* | -238.7% |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
The Goldman Sachs Group (GS) carries a "Neutral" signal with -3.8% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Financials and Healthcare sectors.